|
|
Suppliers for
Trilostane
|
Properties | CAS |
13647-35-3 | Formula |
C20H27NO3 | EINECS |
237-133-0 |
|
|
27 Registered suppliers
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
EINECS :237-133-0 Molecular formula :C20H27NO3
EINECS :237-133-0 Molecular formula :C20H27NO3
EINECS :237-133-0 Molecular formula :C20H27NO3
EINECS :237-133-0 Molecular formula :C20H27NO3
EINECS :237-133-0 Molecular formula :C20H27NO3
More details are to be found here
More details are to be found here
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Detailed information on the suppliers of
Trilostane
|
Properties:
... more properties and specification on Trilostane
|
|
Privileged suppliers
Last update 2024-05-31
|